Alivus Life Sciences (BOM:543322) Short Ratio

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:543322 Alivus Life Sciences Ltd BOM:543322
76 GF Score
Price ₹1,385.15
GF Value ₹1,051.28
Valuation Significantly Overvalued
! 7 Warning Signs
View Full Analysis

What is Alivus Life Sciences Short Ratio?

Short Ratio is a metric signaling prevailing investors' sentiment with a company. It represents the number of days it takes short sellers on average to repurchase all the shares short.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

BOM:543322
76GF Score
Alivus Life Sciences Ltd BOM:543322
Short Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Alivus Life Sciences (BOM:543322) Overvalued in 2026?

Based on GuruFocus' analysis, Alivus Life Sciences stock appears to be overvalued. The current stock price of ₹1,385.15 is trading 31.8% above its estimated GF Value™ of ₹1,051.28. GuruFocus considers Alivus Life Sciences to be Significantly Overvalued.

Key valuation signals for BOM:543322:

  • Short Ratio:
  • GF Value™: ₹1,051.28 vs. price of ₹1,385.15 (31.8% above fair value)
  • GF Score™: 76/100 with 7 warning signs

No single metric tells the full story. See the BOM:543322 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Alivus Life Sciences Business Description

Other Exchanges ALIVUS:India
Address 470, Cardinal Gracious Road, 4th Floor, OIA House, Andheri (East), Mumbai, MH, IND, 400 099
Alivus Life Sciences Ltd develops, manufactures, and supplies high-quality active pharmaceutical ingredients for cardiovascular disease, central nervous system disorders, pain management, diabetes, urology, gastrointestinal disorders, and other therapeutic areas.
76GF Score

Get the complete analysis for BOM:543322

Short Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹1,385.15
Price
₹1,051.28
GF Value